Published in Am J Obstet Gynecol on March 01, 1994
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol (2014) 1.32
Emerging Sexual Health Issues Among Women Who Have Sex with Women. Curr Infect Dis Rep (2012) 1.02
Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol (2009) 0.99
Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol (2001) 0.86
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol (2006) 0.82
Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome (2016) 0.80
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Sex Transm Dis (2015) 0.79
Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review. Infect Dis Obstet Gynecol (1998) 0.78
Bacterial vaginosis treatment evaluation before one month is not accurate. Am J Obstet Gynecol (1995) 0.78
Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease. Infect Dis Obstet Gynecol (1995) 0.75
Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis (2017) 0.75
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect (2005) 2.01
Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol (1993) 1.80
Maternal and perinatal long-chain fatty acids: possible roles in preterm birth. Am J Obstet Gynecol (1997) 1.76
Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol (1995) 1.66
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2007) 1.64
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2007) 1.57
In vivo protective performance of N95 respirator and surgical facemask. Am J Ind Med (2006) 1.56
Old age as a criterion for trauma team activation. J Trauma (2001) 1.53
Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol (1993) 1.45
Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol (1989) 1.42
Does maternal genital herpes infection influence fetal gender? Am J Obstet Gynecol (1990) 1.39
BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol (1991) 1.33
Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials (1998) 1.27
Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol (1986) 1.26
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol (1995) 1.26
Intraamniotic infection in low-birth-weight infants. J Infect Dis (1988) 1.26
Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol (2001) 1.21
Prophylactic antibiotics unjustified for unselected abortion patients. Am J Obstet Gynecol (1985) 1.20
Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol (1996) 1.19
Effect on outcome of early intensive management of geriatric trauma patients. Br J Surg (2002) 1.18
Clinical and microbiological characterization of patients with nonspecific vaginosis associated with motile, curved anaerobic rods. J Infect Dis (1984) 1.15
Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol (2004) 1.13
Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases. Genitourin Med (1991) 1.12
Life-threatening puerperal infection due to group A streptococci. Obstet Gynecol (1992) 1.12
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis (1999) 1.11
Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol (1986) 1.10
The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases. Genitourin Med (1991) 1.09
Reference accuracy in the emergency medicine literature. Ann Emerg Med (1993) 1.06
Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol (1990) 1.06
Accounting for the impact of conservation on human well-being. Conserv Biol (2014) 1.05
Autonomic hyperreflexia: a mortal danger for spinal cord-damaged women in labor. Am J Obstet Gynecol (1985) 1.04
Colonization of the female genital tract with Staphylococcus saprophyticus. J Clin Microbiol (1992) 1.04
Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol (1990) 1.02
Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod (1999) 1.01
Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides. J Antibiot (Tokyo) (1982) 0.99
A central theory of preterm and term labor: putative role for corticotropin-releasing hormone. Am J Obstet Gynecol (1999) 0.99
Oral contraception and the recognition of endometritis. Am J Obstet Gynecol (1997) 0.97
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med (2000) 0.97
Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol (2001) 0.97
Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol (1992) 0.97
Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol (2000) 0.97
Evaluation and management of acute uvular edema. Ann Emerg Med (1993) 0.96
A survey of practices in infectious diseases by obstetrician-gynecologists. Obstet Gynecol (1994) 0.95
Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis (2001) 0.95
Comparison of Diamond's medium modified and Kupferberg medium for detection of Trichomonas vaginalis. J Clin Microbiol (1989) 0.94
Amniotic fluid index values after preterm premature rupture of the membranes and subsequent perinatal infection. Am J Obstet Gynecol (2000) 0.94
Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol (1992) 0.94
A new proline aminopeptidase assay for diagnosis of bacterial vaginosis. Am J Obstet Gynecol (1991) 0.94
Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. Int Arch Occup Environ Health (2005) 0.93
Bacterial vaginosis: diagnostic and pathogenetic findings during topical clindamycin therapy. Am J Obstet Gynecol (1990) 0.93
Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis (1994) 0.92
The presentation of tetanus in an emergency department. J Emerg Med (1998) 0.92
Bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol (1987) 0.92
Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol (1994) 0.92
Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: risk for preterm birth and benefit of treatment. Obstet Gynecol (1999) 0.92
Bacteria and inflammatory cells reduce chorioamniotic membrane integrity and tensile strength. Obstet Gynecol (1989) 0.92
Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis. Genitourin Med (1991) 0.91
Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol (1984) 0.91
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults. Clin Vaccine Immunol (2009) 0.91
Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol (2000) 0.91
Pelvic inflammatory disease in the postmenopausal woman. Infect Dis Obstet Gynecol (1999) 0.90
Varicella zoster antibody testing in the care of pregnant women exposed to varicella. Am J Obstet Gynecol (1987) 0.90
Miliary tuberculosis: unusual cause of abdominal pain in pregnancy. South Med J (1992) 0.90
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. Am J Obstet Gynecol (2001) 0.89
Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Am J Obstet Gynecol (2000) 0.89
Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol (2000) 0.88
Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol (1994) 0.88
Cervicovaginal peroxidases: markers of the fertile period. Obstet Gynecol (1986) 0.88
Trichomonas vaginalis Weakens human Amniochorion in an in vitro model of premature membrane rupture. Infect Dis Obstet Gynecol (1995) 0.88
Low prevalence of Toxoplasma infection in a Rocky Mountain prenatal population. Obstet Gynecol (1987) 0.88
Detection of Trichomonas vaginalis using the polymerase chain reaction in pregnant and non-pregnant women. Infect Dis Obstet Gynecol (1994) 0.87
Guaiacol peroxidase levels in human cervical mucus: a possible predictor of ovulation. Contraception (1982) 0.87
The pathobiology of premature rupture of membranes. Semin Perinatol (1996) 0.87
Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans (2002) 0.86
Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor. Am J Obstet Gynecol (1993) 0.86
Effectiveness of a rescue dose of antenatal betamethasone after an initial single course. Am J Obstet Gynecol (2001) 0.86
Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behav Res Ther (2009) 0.85
Single-dose antibiotic prophylaxis in women undergoing vaginal hysterectomy. Obstet Gynecol (1987) 0.85
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Am J Clin Pathol (1998) 0.85
Molecular cloning of cDNA encoding a 55-kDa multifunctional thyroid hormone binding protein of skeletal muscle sarcoplasmic reticulum. J Biol Chem (1990) 0.84
Is betamethasone effective longer than 7 days after treatment? Obstet Gynecol (2001) 0.84
A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis. Sex Transm Dis (1998) 0.84
Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol (2000) 0.84
Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients. Am J Obstet Gynecol (1986) 0.83
New perspectives on the prevention of extreme prematurity. Clin Obstet Gynecol (1995) 0.83
Vaginal flora in postmenopausal women: the effect of estrogen replacement. Infect Dis Obstet Gynecol (1993) 0.83
Clostridial myonecrosis arising from an episiotomy. Obstet Gynecol (1986) 0.83
Short cervix: a cause of preterm delivery in young adolescents? J Matern Fetal Med (2001) 0.82
Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infect Dis Obstet Gynecol (2001) 0.82
Idiopathic facial nerve paralysis (Bell's palsy) in late pregnancy and the early puerperium. Obstet Gynecol (1987) 0.82
Adolescent misadventures with urethritis and cervicitis. J Adolesc Health Care (1985) 0.82
Infection and phagocytosis as possible mechanisms of rupture in premature rupture of the membranes. Am J Obstet Gynecol (1985) 0.82
Results of a multicenter comparative study of single-dose cefotetan and multiple-dose cefoxitin as prophylaxis in patients undergoing cesarean section. Am J Surg (1988) 0.82
"Fig leaf" ferning and positive Nitrazine testing: semen as a cause of misdiagnosis of premature rupture of membranes. Am J Obstet Gynecol (1985) 0.82
Is trichomoniasis often associated with bacterial vaginosis in pregnant adolescents? Am J Obstet Gynecol (1992) 0.82
Ectopic pregnancy in an urban teaching hospital: can tubal rupture be predicted? South Med J (1991) 0.81
Infection-induced activation of cell-mediated immunity: possible mechanism for preterm birth. Clin Obstet Gynecol (1991) 0.81
Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. Sex Transm Dis (2001) 0.81
Radiographic diagnosis of ankle fractures: are three views necessary? Foot Ankle Int (1994) 0.81